Latest From OpGen Inc.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced July 2017.
Recent regulatory events and dealmaking highlight an increase in the pace of innovation in rapid infectious disease testing.
Recent executive-level company changes and promotions in the medical device and diagnostics industries.
Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
Drug Discovery Tools
- Drug Discovery Tools
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
- Research, Analytical Equipment & Supplies
- Therapeutic Areas
- Infectious & Viral Diseases
- North America
- Parent & Subsidiaries
- OpGen Inc.
- Senior Management
Evan Jones, Chmn. & CEO
Timothy Dec, CFO
Robert Lilley, Chief Commercial Officer
Terry Walker, PhD, SVP, R&D
- Contact Info
Phone: (301) 869-9683
708 Quince Orchard Rd.
Gaithersburg, MD 20878
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.